KhattabAHaiderSKumarA, et al. Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Proc Natl Acad Sci U S A. 2017;114(10):E1933-E1940. doi:10.1073/pnas.1621082114.
3.
PapernaTGershoni-BaruchRBadarnehKKasinetzLHochbergZ.Mutations in CYP11B1 and congenital adrenal hyperplasia in Moroccan Jews. J Clin Endocrinol Metab. 2005;90(9):5463-5465. doi:10.1210/jc.2005-1145.
4.
ZachmannMTassinariDPraderA.Clinical and biochemical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. A study of 25 patients. J Clin Endocrinol Metab. 1983;56(2):222-229. doi:10.1210/jcem-56-2-222.
5.
Al-JurayyanNAAl-HerbishASAbo BakrAM, et al. Congenital adrenal hyperplasia in a referral hospital in Saudi Arabia: epidemiology, pattern and clinical presentation. Ann Saudi Med. 1995;15(5):447-450. doi:10.5144/0256-4947.1995.447.
6.
RöslerALeibermanESackJ, et al. Clinical variability of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. Horm Res. 1982;16(3):133-141. doi:10.1159/000179494.
7.
HonourJWAndersonJMShackletonCHL. Difficulties in the diagnosis of congenital adrenal hyperplasia in early infancy: the 11 β-hydroxylase defect. Eur J Endocrinol. 1983;103(1):101-109. doi:10.1530/acta.0.1030101.
8.
BulsariKFalhammarH.Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Endocrine. 2017;55(1):19-36. doi:10.1007/s12020-016-1189-x.
9.
WangDWangJTongTYangQ.Non-classical 11β-hydroxylase deficiency caused by compound heterozygous mutations: a case study and literature review. J Ovarian Res. 2018;11(1):82. doi:10.1186/s13048-018-0450-8.
